Pages
Products

KAT2A


Official Full Name
lysine acetyltransferase 2A
Organism
Homo sapiens
Gene ID
2648
Background
KAT2A, or GCN5, is a histone acetyltransferase (HAT) that functions primarily as a transcriptional activator. It also functions as a repressor of NF-kappa-B (see MIM 164011) by promoting ubiquitination of the NF-kappa-B subunit RELA (MIM 164014) in a HAT-independent manner (Mao et al., 2009 [PubMed 19339690]).[supplied by OMIM, Sep 2009]
Synonyms
GCN5; hGCN5; GCN5L2; PCAF-b

Cat.No. Product Name Price
SHH036623 shRNA set against Mouse Epm2aip1(NM_175266.4) Inquiry
SHH080219 shRNA set against Human GCN5L2(NM_021078.2) Inquiry
SHH286557 shRNA set against Human EPM2AIP1 (NM_014805.3) Inquiry
SHH286561 shRNA set against Mouse EPM2AIP1 (NM_175266.4) Inquiry
SHH322415 shRNA set against Human KAT2A (NM_021078.2) Inquiry
SHH322419 shRNA set against Mouse KAT2A (NM_020004.5) Inquiry
SHH322423 shRNA set against Rat KAT2A (NM_001107050.1) Inquiry
Cat.No. Product Name Price
CDCL122589 Human KAT2A ORF clone (NM_021078.2) Inquiry
CDFR006760 Rat Kat2a cDNA Clone(NM_001107050.1) Inquiry
MiUTR1H-03989 KAT2A miRNA 3'UTR clone Inquiry
MiUTR1M-04438 EPM2AIP1 miRNA 3'UTR clone Inquiry
CDCB158342 Human EPM2AIP1 ORF clone (BC064696) Inquiry
CDCB181507 Rabbit EPM2AIP1 ORF clone (XM_008266130.1) Inquiry
CDCB189150 Rabbit KAT2A ORF clone (XM_008271494.1) Inquiry
CDCH018751 Mouse EPM2AIP1 ORF clone(NM_175266.4) Inquiry
CDCR232960 Mouse Kat2a ORF Clone(NM_001038010.2) Inquiry
CDCR254684 Mouse Kat2a ORF Clone(NM_020004.5) Inquiry
CDCR373783 Rat Kat2a ORF Clone(NM_001107050.1) Inquiry
CDCS413785 Human EPM2AIP1 ORF Clone (BC064696) Inquiry
CDCS415263 Human KAT2A ORF Clone (BC032743) Inquiry

Detailed Information

Recent Research

KAT2A, a member of the GCN5-related N- acetyltransferase (GNAT) superfamily, was identified as a histone acetyltransferase (HAT) that binds to acetyl-CoA and transfers its acetyl group to histones. The α-ketoglutarate dehydrogenase (α- KGDH) complex is localized in the nucleus in human cell lines and binds to KAT2A in the promoter regions of genes. Some reports showed that the crystal structure of the catalytic domain of KAT2A in complex with succinyl-coenzyme A (succinyl-CoA) at 2.3 Å resolution shows that succinyl-CoA binds to a deep cleft of KAT2A with the succinyl moiety pointing towards the end of a flexible loop 3, which adopts different structural conformations in succinyl-CoA-bound and acetyl-CoA-bound forms. CoA competes with succinyl-CoA to bind to KAT2A and that the CoA group in succinyl-CoA is involved in its interaction with KAT2A. KAT2A acts as succinyltransferase and succinylates histone H3 on lysine 79, with a maximum frequency around the transcription start sites of genes. Preventing the α-KGDH complex from entering the nucleus, or expresses KAT2A, reduces gene expression and inhibits tumor cell proliferation and tumor growth. It has been demonstrated that local generation of succinyl-CoA by the nuclear α-KGDH complex coupled with the succinyltransferase activity of KAT2A is instrumental in histone succinylation, tumor cell proliferation and tumor development.

Some reports showed that KAT2A and KAT2B regulate TBX5 transcriptional activity. TBX5, a T-box transcription factor, is a master regulator of cardiac development. In fact, both KAT2A and KAT2B physically interact with TBX5 in vitro and acetylate it at Lys339. Acetylation enhances its transcriptional activity and is necessary for its nuclear output. While in vivo, knockdown of KAT2A or KAT2B produced both heart and fin phenotypes similar to that observed in TBX5 mutants, which includes incomplete heart looping, pericardial oedema, lack of blood flow into the heart and absence of functional fins.

KAT2A and KAT2B are mainly studied as HATs that acetylate preferentially histone H3 and to a lesser extent H4, leading to changes in chromatin structure. However, KAT2A/KAT2B can also function as a repressor of NF-kappa-B by promoting ubiquitination of the NF-kappa-B subunit RELA in a HAT-independent manner. Recently, it has found one KAT2A/2B substrate, polo-like kinase 4 (PLK4), a key regulator of centrosome duplication. It has been shown that KAT2A/2B acetylates the PLK4 kinase domain on residues K45 and K46. Molecular dynamics modelling suggests that K45/K46 acetylation impairs kinase activity by shifting the kinase to an inactive conformation. Accordingly, PLK4 activity is reduced upon in vitro acetylation of its kinase domain. Moreover, the over-expression of the PLK4 K45R/K46R mutant in cells does not lead to centrosome over-amplification. Impairing KAT2A/2B- acetyltransferase activity results in diminished phosphorylation of PLK4 and in excess centrosome numbers in cells.

References:

  1. Ghosh T K, et al. Acetylation of TBX5 by KAT2B and KAT2A regulates heart and limb development. Journal of Molecular & Cellular Cardiology, 2018, 114.
  2. Fournier M, et al. KAT2A/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in preventing centrosome amplification. Nature Communications, 2016, 7:13227.
  3. Wang Y, et al. KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase. Nature, 2017, 552(7684):273-277.
  4. Li T, Su L, et al. DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells. Journal of Biological Chemistry, 2015, 290(17):11108.
Quick Inquiry